Indian Pharmaceutical Market Outlook - Enhanced Purchasing Power, Rural Market Penetration And Expanded Access To Healthcare Attracting Big Pharma Investment
The Indian government has implemented various initiatives to increase insurance coverage and reduce healthcare costs, such as the National Rural Health Mission and Jan Aushadhi. A revised pricing policy was also proposed in 2011, which will increase government control to over 60% of drugs.
Rising income levels, changing disease patterns, increasing reach of healthcare, reduced out-of-pocket expenditure and growth of new products such as generics and biosimilars are expected to drive growth in the future.Scope - Macroeconomic environment of the pharmaceutical industry in India, covering demographic analysis, drivers, and barriers - Important industry characteristics, looking at healthcare policies, regulations, distribution, pricing, taxation, spending, insurance and reimbursement - Market analysis of segments such as prescription medicines, biotechnology, over-the-counter medicines and Contract Research and Manufacturing Services (CRAMS) - Annualized market data from 2005 to 2010 for important therapeutic segments - Competitive profiling of five major domestic and international companies operating in the Indian pharmaceutical market - Analysis of licensing, partnership and M&A deals that took place between 2007 and 2011 Reasons to buy - Develop market-entry and market-expansion strategies by identifying the leading segments poised for strong growth - Device a more tailored country strategy through understanding key drivers of and barriers to the pharmaceutical market - Develop key strategic initiatives by understanding leading companies' key focus areas - Accelerate and strengthen your market position by identifying key companies for M&A and strategic partnerships Table of Contents 1 Table of Contents 5 1.1 List of Tables 8 1.2 List of Figures 9 2 Indian Pharmaceutical Market Outlook – Introduction 10 3 Indian Pharmaceutical Market Outlook – Overview 11 3.1 Global Pharmaceutical Industry Landscape 11 3.2 Macro View of the Indian Pharmaceutical Sector 12
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts